Requires 16-week dose escalation for weight management
Why Choose Southern Care Anesthetics for BPC-157 Peptide Therapy
Oxid Med Cell Longev, 2019
Novo Nordisk, Ozempics manufacturer, faces over 2,000 people claiming they developed severe gastrointestinal conditions after taking the drug
This injection has been described as a game changer
With Ozempic now available as both an injection and oral option under one brand, treatment can be individualised so patients are getting the proven semaglutide medicine that best fits their needs. In March 2026, Novo Nordisk received US FDA approval for a high-dose version of Wegovy (semaglutide), its weight loss therapy, as patents supporting the drugs market exclusivity moved closer to expiry in some markets